Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Main conditions treated with prescribed vs illicit medical cannabis

From: Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)

 

Prescribed (n = 2331)

Illicit (n = 862)

Total (N = 3193)

OR (95% CI)

Pain

888 (38%)

283 (33%)

1171 (37%)

P/I: 1.3 (1.1, 1.5)

Mental health/substance Use

795 (34%)

343 (40%)

1138 (36%)

P/I: 0.8 (0.7, 0.9)

Sleep

381 (16%)

109 (13%)

490 (15%)

P/I: 1.4 (1.1, 1.7)

Neurological

105 (5%)

53 (6%)

158 (5%)

P/I: 0.7 (0.5, 1.1)

Gastrointestinal

52 (2%)

18 (2%)

70 (2%)

P/I: 1.1 (0.6, 2.0)

Cancer

19 (1%)

16 (2%)

35 (1%)

P/I: 0.4 (0.2, 0.9)

Other

91 (4%)

40 (5%)

131 (4%)

P/I: 0.8 (0.6, 1.3)

  1. Significant differences in bold